Expanding the phenotypic spectrum in RDH12-associated retinal disease
Hilary Scott(Massachusetts Eye and Ear Infirmary), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Naomi E. Wagner(Massachusetts Eye and Ear Infirmary), Erin Zampaglione(Massachusetts Eye and Ear Infirmary), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Katherine R. Chao(Broad Institute), Daniel Navarro-Gomez, Kevin Ferenchak(Mayo Clinic), Eric A. Pierce(Broad Institute), Shizuo Mukai(Massachusetts Eye and Ear Infirmary), Emily Place(MACOM (United States)), Stephanie DiTroia(Broad Institute)
Cited by 31
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k